GlassScriptPhysician profile
Danielle Rae Manship
NPI 1386221935
$1,106.79
in general payments reported to CMS, 2019-2025
11 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $139 · 2023: $44.64 · 2024: $566 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643 · Education: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.70 |
| Education | $325.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $325.00 | 2024 | |
| Coloplast Corp | $170.94 | 2025 | |
| Alexion Pharmaceuticals, INC. | $121.81 | 2024 | |
| Minerva Surgical, INC | $113.00 | 2025 | |
| Medtronic, INC. | $100.69 | 2022 | |
| Sage Therapeutics, LLC | $95.34 | 2024-2025 | Zurzuvae |
| Organon LLC | $70.42 | 2023-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $38.40 | 2022 | |
| Axonics, INC. | $34.01 | 2023-2024 | Bulkamid |
| Baxter Healthcare | $21.16 | 2025 | Perclot |
| Exeltis, USA INC. | $16.02 | 2025 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Manship listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.